Research confirms the Lumipulse serum p-tau217 assay's effectiveness in diagnosing Alzheimer's, paving the way for accessible ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread ...

Ellen’s experience highlights the growing promise of blood-based testing for Alzheimer’s. By identifying disease-specific biomarkers in the bloodstream, these tests offer a minimally invasive ...

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

Researchers developing benchmarks for a blood-based test like those for measuring blood glucose and cholesterol ...

The interaction between the brain and the vascular system could hold the key to lowering disease risk. According to the ...

Alzheimer’s blood tests are the key to widespread prevention of dementia, experts say. If people can be diagnosed in their doctor’s office, they can more immediately move into preventive care ...

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund ...